$0.880100
~00.01%
At Close: -
$0.880000
~0-0.01%
After Hours: 7:24 PM EDT
15 minutes delayed
Predictive Oncology reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Predictive Oncology using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Dec 2022 | 2023-03-21 | $-2.00 | $-1.20 | -66.7 % |
Dec 2021 | 2022-03-31 | $-2.60 | $-0.40 | -550.0 % |
Sep 2021 | 2021-11-10 | $-1.60 | $-1.00 | -60.0 % |
Jun 2021 | 2021-08-11 | $-1.00 | $-1.40 | 28.6 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Jun 2022 | 2022-08-11 | $371.59K | $2.00M | -81.4 % |
Sep 2021 | 2021-11-10 | $313.66K | $1.20M | -73.9 % |
Jun 2021 | 2021-08-11 | $350.21K | $600.00K | -41.6 % |
Mar 2021 | 2021-05-12 | $280.32K | $400.00M | -99.9 % |
Predictive Oncology (POAI) is scheduled to report earnings on November 12, 2024. The last reported earnings were for reported on August 13, 2024 for Q2.
The Actual EPS was $-0.68, which missed the estimate of $0.00.
The Actual Revenue was $278.7K, which beat the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.